Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Family Practice|June 15, 2010
The importance and treatment of postprandial hyperglycemiaTimothy S Reid
Hospital Practice (1995)|September 26, 2014
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, for the management of type 2 diabetesStephen Brunton, Timothy S Reid
The Journal of Family Practice|October 2, 2013
Integrating advances in insulin into clinical practice: Effective utilization of insulin in patient managementMichael K Heile, Timothy S Reid
The Journal of Family Practice|January 25, 2019
The Relevance of Clinical Pharmacology Studies of Basal Insulins to Primary CareTimothy S Reid, John White, Luigi Meneghini
Postgraduate Medicine|May 6, 2017
Higher concentration insulins: an overview of clinical considerationsTimothy S Reid, Fryn Schafer, Cynthia Brusko
Clinical Diabetes : a Publication of the American Diabetes Association|October 30, 2019
Practical Guidance on Effective Basal Insulin Titration for Primary Care ProvidersLouis Kuritzky, Timothy S Reid, Carol H Wysham
The Journal of Family Practice|September 9, 2010
Distinguishing among incretin-based therapies. IntroductionR Keith Campbell, Michael E Cobble, Timothy S Reid, et al.
The Journal of Family Practice|September 9, 2010
Distinguishing among incretin-based therapies. Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapiesR Keith Campbell, Michael E Cobble, Timothy S Reid, et al.
The Journal of Family Practice|September 9, 2010
Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapiesR Keith Campbell, Michael E Cobble, Timothy S Reid, et al.
The Journal of Family Practice|September 9, 2010
Distinguishing among incretin-based therapies. Patient education and self-managementR Keith Campbell, Michael E Cobble, Timothy S Reid, et al.
Pageof 2